Skip to main content

Table 3 Number of "early" HCC patients treated in adherence with the AASLD guidelines.

From: Early and very early hepatocellular carcinoma: when and how much do staging and choice of treatment really matter? A multi-center study

   ACTUAL TREATMENT
AASLD INDICATIONS   RESECTION OLTx PEI/RFTA TACE/
PEI+TACE
BSC
  RESECTION 30 (28%) 1 (1%) 44 (40%) 27 (25%) 7 (6%)
  OLTx 6 (9%) 6(9%) 9 (14%) 34 (52%) 11(16%)
  PEI or RFTA 32 (13%) 4 (2%) 83 (34%) 88 (36%) 37(15%)
  1. OLTx: orthotopic liver transplantation; RFTA: radiofrequency-mediated thermal ablation; PEI: percutaneous ethanol injection; TACE: transcatheter arterial chemoembolization; BSC: best supportive care.
  2. AASLD indications for treatment are reported in rows; percentages of patients treated per each modality are calculated on the totality of patients having that specific indication.
  3. The adherence to AASLD indication was evaluated when all data were available (419/465 pts – 90%).